4 Results for "

dog coronary artery

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "dog coronary artery" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-12717A
CAS No.: 73-05-2
Purity:  99.87%
Target:  

Adrenergic Receptor

Phentolamine hydrochloride is an orally active, selective α1 and α2 Adrenergic receptor antagonist. Phentolamine hydrochloride antagonizes the vasodilatory effect of Cromakalim (HY-110011) on isolated circumflex coronary artery segments in dogs. Phentolamine hydrochloride reduces systemic vascular resistance and increases cardiac output. Phentolamine hydrochloride improves erectile dysfunction. Phentolamine hydrochloride can be used for the research of erectile dysfunction .
loading...
    loading...
Cat. No.: HY-106523
CAS No.: 81486-22-8
Synonyms: KT 210; K 351; Hypadil
Target:  

Adrenergic Receptor

Research Areas:  

Cardiovascular Disease

Nipradolol (KT-210; K-351) is a potent blocker of alpha-1-adrenergic receptors. Nipradolol inhibits the increase of intraocular pressure (IOP) in an albino rabbit model induced by Phenylephrine (HY-B0769). Nipradolo suppresses the noradrenaline (NA)-induced muscles contraction, also exhibits vasodilator activity on the dog coronary artery .
loading...
    loading...
Cat. No.: HY-114920
CAS No.: 40680-87-3
Target:  

Calcium Channel

Research Areas:  

Cardiovascular Disease

Piprofurol is a calcium channel inhibitor. Piprofurol inhibits the calcium-induced contractions in isolated potassium depolarized preparations of rat aorta in a concentration-dependent manner and relaxes the K +-induced contraction of the dog coronary artery and the rabbit basilar artery. Piprofurol exerts a negative inotropic effect on guinea-pig papillary muscle, with the EC50 of 5 μM .
loading...
    loading...
Cat. No.: HY-105209
CAS No.: 132722-74-8
Target:  

Endogenous Metabolite

Research Areas:  

Cardiovascular Disease

Pirsidomine is a nitric oxide donor. Pirsidomine is a sydnonimine compound. Pirsidomine can transform into a nitric oxide-releasing metabolite in vivo. Pirsidomine prevents occlusion-induced increase in flow in the non-occluded circumflex coronary artery and significantly reduces the blood flow in non-ischemic areas in myocardial infarction dog model. Pirsidomine can be studied in research on cardiovascular diseases .
loading...
    loading...